New Software Package Released for Compatibility of MRI Scanners with Post-Processing Tools
By MedImaging International staff writers Posted on 21 Dec 2015 |
New software that enhances the efficiency of the Magnetic Resonance Imaging (MRI) workflow, and clinical decision has been released.
The release is part of a cooperation and co-marketing agreement between a software company and a major manufacturer of MRI scanners. The software upgrade is optional, and makes MRI scanners compatible with the post-processing software packages from the software vendor.
Philips Healthcare, is offering the SyntheticMR, SyntAc sequence software to customers. The SyntAc will enable most Philips MRI customers to use the SyMRI post-processing software packages. The SyntheticMR, SyMRI software can use the data from one SyntAc scan and convert this into several image contrasts, even after the scan has taken place, without re-calling the patient for multiple scans. The need for only a single scan saves time and simplifies workflow. Another feature of the SyMRI software is automatic segmentation of brain tissue, with quantitative data and objective decision support.
There are three versions of the SyMRI software. The SyMRI IMAGE package can optimize workflows and short scan times using a single MR quantification scan. The SyMRI NEURO package aids analysis and decision making during brain imaging for the follow-up in the development of neurodegenerative diseases, by adding quantitative data. The SyMRI Research Edition is intended for neuro imaging clinical research, and provides quantitative T1, T2 and PD maps (SyMaps) that can be stored and exported in other formats.
Stefan Tell, CEO of SyntheticMR, said, “I am very pleased that customers using most Philips MRI scanners will now have access to SyMRI, expanding our software packages to a broader, global customer base and enabling them to explore new imaging strategies and efficient quantification capabilities.”
Related Links:
SyntheticMR
Philips Healthcare
The release is part of a cooperation and co-marketing agreement between a software company and a major manufacturer of MRI scanners. The software upgrade is optional, and makes MRI scanners compatible with the post-processing software packages from the software vendor.
Philips Healthcare, is offering the SyntheticMR, SyntAc sequence software to customers. The SyntAc will enable most Philips MRI customers to use the SyMRI post-processing software packages. The SyntheticMR, SyMRI software can use the data from one SyntAc scan and convert this into several image contrasts, even after the scan has taken place, without re-calling the patient for multiple scans. The need for only a single scan saves time and simplifies workflow. Another feature of the SyMRI software is automatic segmentation of brain tissue, with quantitative data and objective decision support.
There are three versions of the SyMRI software. The SyMRI IMAGE package can optimize workflows and short scan times using a single MR quantification scan. The SyMRI NEURO package aids analysis and decision making during brain imaging for the follow-up in the development of neurodegenerative diseases, by adding quantitative data. The SyMRI Research Edition is intended for neuro imaging clinical research, and provides quantitative T1, T2 and PD maps (SyMaps) that can be stored and exported in other formats.
Stefan Tell, CEO of SyntheticMR, said, “I am very pleased that customers using most Philips MRI scanners will now have access to SyMRI, expanding our software packages to a broader, global customer base and enabling them to explore new imaging strategies and efficient quantification capabilities.”
Related Links:
SyntheticMR
Philips Healthcare
Latest Imaging IT News
- New Google Cloud Medical Imaging Suite Makes Imaging Healthcare Data More Accessible
- Global AI in Medical Diagnostics Market to Be Driven by Demand for Image Recognition in Radiology
- AI-Based Mammography Triage Software Helps Dramatically Improve Interpretation Process
- Artificial Intelligence (AI) Program Accurately Predicts Lung Cancer Risk from CT Images
- Image Management Platform Streamlines Treatment Plans
- AI-Based Technology for Ultrasound Image Analysis Receives FDA Approval
- AI Technology for Detecting Breast Cancer Receives CE Mark Approval
- Digital Pathology Software Improves Workflow Efficiency
- Patient-Centric Portal Facilitates Direct Imaging Access
- New Workstation Supports Customer-Driven Imaging Workflow
Channels
Radiography
view channel
Novel Breast Imaging System Proves As Effective As Mammography
Breast cancer remains the most frequently diagnosed cancer among women. It is projected that one in eight women will be diagnosed with breast cancer during her lifetime, and one in 42 women who turn 50... Read more
AI Assistance Improves Breast-Cancer Screening by Reducing False Positives
Radiologists typically detect one case of cancer for every 200 mammograms reviewed. However, these evaluations often result in false positives, leading to unnecessary patient recalls for additional testing,... Read moreMRI
view channel
PET/MRI Improves Diagnostic Accuracy for Prostate Cancer Patients
The Prostate Imaging Reporting and Data System (PI-RADS) is a five-point scale to assess potential prostate cancer in MR images. PI-RADS category 3 which offers an unclear suggestion of clinically significant... Read more
Next Generation MR-Guided Focused Ultrasound Ushers In Future of Incisionless Neurosurgery
Essential tremor, often called familial, idiopathic, or benign tremor, leads to uncontrollable shaking that significantly affects a person’s life. When traditional medications do not alleviate symptoms,... Read more
Two-Part MRI Scan Detects Prostate Cancer More Quickly without Compromising Diagnostic Quality
Prostate cancer ranks as the most prevalent cancer among men. Over the last decade, the introduction of MRI scans has significantly transformed the diagnosis process, marking the most substantial advancement... Read moreUltrasound
view channel
Deep Learning Advances Super-Resolution Ultrasound Imaging
Ultrasound localization microscopy (ULM) is an advanced imaging technique that offers high-resolution visualization of microvascular structures. It employs microbubbles, FDA-approved contrast agents, injected... Read more
Novel Ultrasound-Launched Targeted Nanoparticle Eliminates Biofilm and Bacterial Infection
Biofilms, formed by bacteria aggregating into dense communities for protection against harsh environmental conditions, are a significant contributor to various infectious diseases. Biofilms frequently... Read moreNuclear Medicine
view channel
New SPECT/CT Technique Could Change Imaging Practices and Increase Patient Access
The development of lead-212 (212Pb)-PSMA–based targeted alpha therapy (TAT) is garnering significant interest in treating patients with metastatic castration-resistant prostate cancer. The imaging of 212Pb,... Read more
New Radiotheranostic System Detects and Treats Ovarian Cancer Noninvasively
Ovarian cancer is the most lethal gynecological cancer, with less than a 30% five-year survival rate for those diagnosed in late stages. Despite surgery and platinum-based chemotherapy being the standard... Read more
AI System Automatically and Reliably Detects Cardiac Amyloidosis Using Scintigraphy Imaging
Cardiac amyloidosis, a condition characterized by the buildup of abnormal protein deposits (amyloids) in the heart muscle, severely affects heart function and can lead to heart failure or death without... Read moreGeneral/Advanced Imaging
view channel
New AI Method Captures Uncertainty in Medical Images
In the field of biomedicine, segmentation is the process of annotating pixels from an important structure in medical images, such as organs or cells. Artificial Intelligence (AI) models are utilized to... Read more.jpg)
CT Coronary Angiography Reduces Need for Invasive Tests to Diagnose Coronary Artery Disease
Coronary artery disease (CAD), one of the leading causes of death worldwide, involves the narrowing of coronary arteries due to atherosclerosis, resulting in insufficient blood flow to the heart muscle.... Read more
Novel Blood Test Could Reduce Need for PET Imaging of Patients with Alzheimer’s
Alzheimer's disease (AD), a condition marked by cognitive decline and the presence of beta-amyloid (Aβ) plaques and neurofibrillary tangles in the brain, poses diagnostic challenges. Amyloid positron emission... Read more.jpg)
CT-Based Deep Learning Algorithm Accurately Differentiates Benign From Malignant Vertebral Fractures
The rise in the aging population is expected to result in a corresponding increase in the prevalence of vertebral fractures which can cause back pain or neurologic compromise, leading to impaired function... Read moreIndustry News
view channel
Bayer and Google Partner on New AI Product for Radiologists
Medical imaging data comprises around 90% of all healthcare data, and it is a highly complex and rich clinical data modality and serves as a vital tool for diagnosing patients. Each year, billions of medical... Read more